Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

What they've accomplished so far: The Rays have traded major players -- Shane Baz, Brandon Lowe, and Jake Mangum -- in two ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

Over $100 million deal strengthens AppDirect’s position as the leading B2B commerce platform, adding connectivity and mobility to its unified lifecycle management platform of AI, software, hardware, ...

(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with almost three years of experience, he has focused on establishing himself in the gaming space. While he focuses on ...

A sequel to the 2016 hit, this movie about an animal metropolis takes on an even messier social allegory than the first one, while building out a wider (if bloated) universe. By Brandon Yu When you ...

The Outer Worlds 2 update 1.0.5.0 is here, saving our eyebrows and proving that the devs are keeping a close eye on Reddit, with one niche change potentially a direct response to a post on the site.